ical and 
nonclinical information in their premarket approval application (PMA) 
and the process involved in any related inspections. Premarket 
notification (510(k)) submissions are not addressed in this draft 
guidance because a premarket inspection is not ordinarily conducted for 
510(k)s. This draft guidance is not final nor is it in effect at this 
time.

DATES: Submit written or electronic comments on this draft guidance by 
September 18, 2006.

ADDRESSES: Submit written requests for single